Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Merck & Co., Inc. (MRK:NYSE), powered by AI.
Merck & Co., Inc. is currently trading at $115.17. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Merck & Co., Inc. on Alpha Lenz.
Merck & Co., Inc.'s P/E ratio is 15.8.
“Merck & Co., Inc. trades at a P/E of 15.8 (fair value) with strong ROE of 36.9%. Operating margin of 34.0% indicates strong profitability.”
Ask for details →Merck & Co., Inc. is a prominent player in the global pharmaceutical industry. It is primarily focused on the research, development, production, and marketing of drugs and vaccines. Known for its strong emphasis on innovative health solutions, Merck develops treatments and vaccines for a variety of diseases affecting humans and animals. Key areas include oncology, infectious diseases, diabetes, and vaccines, reflecting its commitment to addressing critical health challenges worldwide. The company operates in several strategic regions, exporting its advanced therapies to meet healthcare needs across different markets. With a robust pipeline of new products and significant investment in research and development, Merck plays a vital role in advancing medical breakthroughs and enhancing patient care. Beyond pharmaceuticals, Merck is involved in animal health, providing veterinary vaccines and services, contributing to agricultural productivity and food security. The company's ongoing efforts in groundbreaking research and public health initiatives underscore its importance in the healthcare sector.
“Merck & Co., Inc. trades at a P/E of 15.8 (fair value) with strong ROE of 36.9%. Operating margin of 34.0% indicates strong profitability.”
Ask for details →Merck & Co., Inc. (ticker: MRK) is a company listed on NYSE in the Healthcare sector (Drug Manufacturers - General). It has approximately 73,000 employees. Market cap is $288.2B.
The current price is $115.17 with a P/E ratio of 15.79x and P/B of 5.48x.
ROE is 36.91% and operating margin is 34.01%. Annual revenue is $65.0B.